
Renalytix PLC (RNLXD) P/E Ratio
P/E Ratio as of Jan 27, 2026: -0.47
Average-0.4475
Median-0.4500
Minimum-0.4700
Maximum-0.4000
-0.47
0.04 (9.30%)past month
The P/E ratio for Renalytix PLC (RNLXD) is -0.47 as of Jan 27, 2026. This represents a decrease of -17.54% compared to its 12-month average P/E ratio of -0.57. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Renalytix PLC P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Renalytix PLC’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Renalytix PLC to industry peers.
Renalytix PLC P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Renalytix PLC’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Renalytix PLC to industry peers.
Renalytix PLC (RNLXD) P/E Ratio Insights
See Renalytix PLC’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Renalytix PLC (RNLXD)
Order type
Buy in
Order amount
Est. shares
0 shares
Renalytix PLC (RNLXD) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Dec 1, 2025 | $4.35 | -0.48 |
| Nov 3, 2025 | $5.25 | -0.58 |
| Oct 1, 2025 | $6.75 | -0.74 |
| Sep 2, 2025 | $4.1656 | -0.46 |
| Aug 1, 2025 | $4.5625 | -0.50 |
| Jul 1, 2025 | $5.00 | -0.55 |
| Jun 2, 2025 | $4.7906 | -0.53 |
| May 1, 2025 | $5.325 | -0.59 |
| Apr 1, 2025 | $5.25 | -0.58 |
| Mar 3, 2025 | $6.625 | -0.73 |
| Feb 3, 2025 | $6.0125 | -0.66 |
| Jan 2, 2025 | $5.8625 | -0.64 |
Renalytix PLC (RNLXD) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | -0.47 | +17.50% |
| 2025 | -0.40 | -31.03% |
| 2024 | -0.58 | +52.63% |
| 2023 | -0.38 | -73.97% |
| 2022 | -1.46 | -88.90% |
| 2021 | -13.15 | — |
FAQs About Renalytix PLC (RNLXD) P/E ratio
The latest P/E ratio of Renalytix PLC (RNLXD) is -0.47, as of Jan 27, 2026. This is calculated based on its current stock price and earnings per share (EPS).
Renalytix PLC’s last 12-month average P/E ratio is -0.57, compared to its current P/E ratio of -0.47. This reflects a decrease of -17.54%.
Renalytix PLC’s current P/E ratio of -0.47 is lower than its last 12-month average P/E of -0.57. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Renalytix PLC’s average P/E ratio over the last 3 years is -1.04. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Renalytix PLC’s average P/E ratio over the last 5 years is -8.17. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.